Haemonetics
HAE
#3420
Rank
โ‚ฌ3.46 B
Marketcap
71,95ย โ‚ฌ
Share price
0.16%
Change (1 day)
-8.34%
Change (1 year)

Revenue for Haemonetics (HAE)

Revenue in 2025 (TTM): โ‚ฌ1.19 Billion

According to Haemonetics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.13 Billion. In 2024 the company made a revenue of โ‚ฌ1.31 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ1.14 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Haemonetics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ1.19 B-9.68%
2024 โ‚ฌ1.31 B14.87%
2023 โ‚ฌ1.14 B9.14%
2022 โ‚ฌ1.05 B25.07%
2021 โ‚ฌ0.84 B17.12%
2020 โ‚ฌ0.71 B-19.44%
2019 โ‚ฌ0.89 B7.21%
2018 โ‚ฌ0.83 B11.12%
2017 โ‚ฌ0.74 B-12.53%
2016 โ‚ฌ0.85 B4.81%
2015 โ‚ฌ0.81 B7.38%
2014 โ‚ฌ0.76 B10.87%
2013 โ‚ฌ0.68 B9.5%
2012 โ‚ฌ0.62 B14.4%
2011 โ‚ฌ0.54 B7.8%
2010 โ‚ฌ0.50 B15.77%
2009 โ‚ฌ0.43 B5.01%
2008 โ‚ฌ0.41 B23.36%
2007 โ‚ฌ0.33 B0.88%
2006 โ‚ฌ0.33 B-2.82%
2005 โ‚ฌ0.34 B22.91%
2004 โ‚ฌ0.28 B1.88%
2003 โ‚ฌ0.27 B-13.93%
2002 โ‚ฌ0.32 B-11.14%
2001 โ‚ฌ0.36 B18.45%
2000 โ‚ฌ0.30 B8.49%
1999 โ‚ฌ0.28 B28.68%
1998 โ‚ฌ0.21 B-16.1%
1997 โ‚ฌ0.26 B3.94%
1996 โ‚ฌ0.25 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ37.48 B 3,193.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
โ‚ฌ20.89 B 1,736.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ18.33 B 1,510.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus
CERS
โ‚ฌ0.17 B-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ9.44 B 730.14%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚ฌ2.87 B 152.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ78.99 B 6,839.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚ฌ29.31 B 2,475.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland